Your browser doesn't support javascript.
loading
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
Chiodin, Giorgia; Allen, Joel D; Bryant, Dean J; Rock, Philip; Martino, Enrica A; Valle-Argos, Beatriz; Duriez, Patrick J; Watanabe, Yasunori; Henderson, Isla; Blachly, James S; McCann, Katy J; Strefford, Jonathan C; Packham, Graham; Geijtenbeek, Teunis B H; Figdor, Carl G; Wright, George W; Staudt, Louis M; Burack, Richard; Bowden, Thomas A; Crispin, Max; Stevenson, Freda K; Forconi, Francesco.
  • Chiodin G; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Allen JD; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
  • Bryant DJ; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Rock P; Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY.
  • Martino EA; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Valle-Argos B; Division of Hematology, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania, Italy.
  • Duriez PJ; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Watanabe Y; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Henderson I; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Blachly JS; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • McCann KJ; Division of Hematology, The Ohio State University, Columbus, OH.
  • Strefford JC; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Packham G; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Geijtenbeek TBH; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
  • Figdor CG; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Wright GW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Staudt LM; Biometric Research Branch, Division of Cancer Diagnosis and Treatment.
  • Burack R; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and.
  • Bowden TA; Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY.
  • Crispin M; Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Stevenson FK; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
  • Forconi F; School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine.
Blood ; 138(17): 1570-1582, 2021 10 28.
Article en En | MEDLINE | ID: mdl-34424958
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polisacáridos / Linfoma de Células B Grandes Difuso / Regiones Determinantes de Complementariedad Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polisacáridos / Linfoma de Células B Grandes Difuso / Regiones Determinantes de Complementariedad Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article